Effect of budesonide transnasal nebulization in patients with eosinophilic chronic rhinosinusitis with nasal polyps

Journal of Allergy and Clinical Immunology

Volumn 135, Issue 4, 2015, Pages 922-929.e6

  Wang, Chengshuo ^a,b   Lou, Hongfei ^a,b   Wang, Xiangdong ^a,b   Wang, Yang ^b   Fan, Erzhong ^b   Li, Ying ^b   Wang, Hong ^b   Bachert, Claus ^c   Zhang, Luo ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

budesonide; Eosinophilic chronic rhinosinusitis; inflammatory cytokine; nasal polyps; T cell subsets; tissue remodeling; transnasal nebulization

Indexed keywords

ALBUMIN; BUDESONIDE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; EOTAXIN; GAMMA INTERFERON; GELATINASE A; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 5; MATRILYSIN; NEUTROPHIL COLLAGENASE; PLACEBO; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TRANSFORMING GROWTH FACTOR BETA; AUTACOID; BRONCHODILATING AGENT; CYTOKINE;

ADULT; AGED; ARTICLE; CELL COUNT; CELL INFILTRATION; CHRONIC RHINOSINUSITIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; EOSINOPHIL; EOSINOPHILIC CHRONIC RHINOSINUSITIS; FEMALE; FLOW CYTOMETRY; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEBULIZATION; NOSE POLYP; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; STAINING; T LYMPHOCYTE SUBPOPULATION; TH2 CELL; TREATMENT OUTCOME; TUMOR VOLUME; VISUAL ANALOG SCALE; CHRONIC DISEASE; CLINICAL TRIAL; COMPLICATION; METABOLISM; MIDDLE AGED; NEBULIZER; PATHOLOGY; RHINITIS; SINUSITIS; YOUNG ADULT;

ADULT; AGED; BRONCHODILATOR AGENTS; BUDESONIDE; CHRONIC DISEASE; CYTOKINES; EOSINOPHILS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NASAL POLYPS; NEBULIZERS AND VAPORIZERS; RHINITIS; SINUSITIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84926260105     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.10.018     Document Type: Article

References (32)

1. W.J. Fokkens, V.J. Lund, J. Mullol, C. Bachert, I. Alobid, and F. Baroody EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists Rhinology 50 2012 1 12
2. N. Van Bruaene, C.A. Perez-Novo, T.M. Basinski, T. Van Zele, G. Holtappels, and N. De Ruyck T-cell regulation in chronic paranasal sinus disease J Allergy Clin Immunol 121 2008 1435 1441 e1-3
3. C. Bachert, P. Gevaert, G. Holtappels, C. Cuvelier, and P. van Cauwenberge Nasal polyposis: from cytokines to growth Am J Rhinol 14 2000 279 290
4. N. Zhang, T. Van Zele, C. Perez-Novo, N. Van Bruaene, G. Holtappels, and N. DeRuyck Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease J Allergy Clin Immunol 122 2008 961 968
5. C.B. Small, P. Stryszak, M. Danzig, and A. Damiano Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis J Allergy Clin Immunol 121 2008 928 932
6. P. Hissaria, W. Smith, P.J. Wormald, J. Taylor, M. Vadas, and D. Gillis Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures J Allergy Clin Immunol 118 2006 128 133
7. S. Vaidyanathan, M. Barnes, P. Williamson, P. Hopkinson, P.T. Donnan, and B. Lipworth Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial Ann Intern Med 154 2011 293 302
8. K. Basu, A. Nair, P.A. Williamson, S. Mukhopadhyay, and B.J. Lipworth Airway and systemic effects of soluble and suspension formulations of nebulized budesonide in asthmatic children Ann Allergy Asthma Immunol 103 2009 436 441
9. K.M. Hvizdos, and B. Jarvis Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders Drugs 60 2000 1141 1178
10. W. Fokkens, V. Lund, and J. Mullol European position paper on rhinosinusitis and nasal polyps 2007 Rhinol Suppl 20 2007 1 136
11. P.P. Cao, H.B. Li, B.F. Wang, S.B. Wang, X.J. You, and Y.H. Cui Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese J Allergy Clin Immunol 124 2009 478 484 e1-2
12. P. Keith, J. Nieminen, K. Hollingworth, and J. Dolovich Efficacy and tolerability of fluticasone propionate nasal drops 400 microgram once daily compared with placebo for the treatment of bilateral polyposis in adults Clin Exp Allergy 30 2000 1460 1468
13. J.W. Steinke, S.C. Payne, M.E. Tessier, L.O. Borish, J.K. Han, and L.C. Borish Pilot study of budesonide inhalant suspension irrigations for chronic eosinophilic sinusitis J Allergy Clin Immunol 124 2009 1352 1354.e7
14. N.S. Sachanandani, J.F. Piccirillo, M.A. Kramper, S.E. Thawley, and A. Vlahiotis The effect of nasally administered budesonide respules on adrenal cortex function in patients with chronic rhinosinusitis Arch Otolaryngol Head Neck Surg 135 2009 303 307
15. R.K. Bhalla, K. Payton, and E.D. Wright Safety of budesonide in saline sinonasal irrigations in the management of chronic rhinosinusitis with polyposis: lack of significant adrenal suppression J Otolaryngol Head Neck Surg 37 2008 821 825
16. K.C. Welch, E.R. Thaler, L.L. Doghramji, J.N. Palmer, and A.G. Chiu The effects of serum and urinary cortisol levels of topical intranasal irrigations with budesonide added to saline in patients with recurrent polyposis after endoscopic sinus surgery Am J Rhinol Allergy 24 2010 26 28
17. D.L. Hamilos Chronic rhinosinusitis: epidemiology and medical management J Allergy Clin Immunol 128 2011 693 709
18. R. Jankowski, C. Schrewelius, P. Bonfils, Y. Saban, L. Gilain, and J.M. Prades Efficacy and tolerability of budesonide aqueous nasal spray treatment in patients with nasal polyps Arch Otolaryngol Head Neck Surg 127 2001 447 452
19. T. Van Zele, P. Gevaert, G. Holtappels, A. Beule, P.J. Wormald, and S. Mayr Oral steroids and doxycycline: two different approaches to treat nasal polyps J Allergy Clin Immunol 125 2010 1069 1076.e4
20. W. Wen, W. Liu, L. Zhang, J. Bai, Y. Fan, and W. Xia Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy J Allergy Clin Immunol 129 2012 1522 1528.e5
21. H.B. Li, K.M. Cai, Z. Liu, J.H. Xia, Y. Zhang, and R. Xu Foxp3+ T regulatory cells (Tregs) are increased in nasal polyps (NP) after treatment with intranasal steroid Clin Immunol 129 2008 394 400
22. X. Li, J. Meng, X. Qiao, Y. Liu, F. Liu, and N. Zhang Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis J Allergy Clin Immunol 125 2010 1061 1068
23. C. Mastruzzo, L.R. Greco, K. Nakano, A. Nakano, F. Palermo, and M.P. Pistorio Impact of intranasal budesonide on immune inflammatory responses and epithelial remodeling in chronic upper airway inflammation J Allergy Clin Immunol 112 2003 37 44
24. S.M. Molet, Q.A. Hamid, and D.L. Hamilos IL-11 and IL-17 expression in nasal polyps: relationship to collagen deposition and suppression by intranasal fluticasone propionate Laryngoscope 113 2003 1803 1812
25. Y.M. Lee, S.S. Kim, H.A. Kim, Y.J. Suh, S.K. Lee, and D.H. Nahm Eosinophil inflammation of nasal polyp tissue: relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1 J Korean Med Sci 18 2003 97 102
26. O. Yigit, E. Acioglu, R. Gelisgen, E.A. Server, E. Azizli, and H. Uzun The effect of corticosteroid on metalloproteinase levels of nasal polyposis Laryngoscope 121 2011 667 673
27. M. Hoshino, M. Takahashi, Y. Takai, and J. Sim Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma J Allergy Clin Immunol 104 1999 356 363
28. M. Namba, K. Asano, K. Kanai, Y. Kyo, S. Watanabe, and T. Hisamitsu Suppression of matrix metalloproteinase production from nasal fibroblasts by fluticasone propionate in vitro Acta Otolaryngol 124 2004 964 969
29. F.M. Bruni, G. De Luca, V. Venturoli, and A.L. Boner Intranasal corticosteroids and adrenal suppression Neuroimmunomodulation 16 2009 353 362
30. W. Fokkens, V. Lund, and J. Mullol European position paper on rhinosinusitis and nasal polyps 2007 Rhinol Suppl 20 2007 1 136
31. P.P. Cao, H.B. Li, B.F. Wang, S.B. Wang, X.J. You, and Y.H. Cui Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese J Allergy Clin Immunol 124 2009 478 484 e1-2
32. X. Li, J. Meng, X. Qiao, Y. Liu, F. Liu, and N. Zhang Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis J Allergy Clin Immunol 125 2010 1061 1068